Novo's weight-loss drug Wegovy cuts risk of heart disease by 20% - trial data

The weight loss drug Wegovy reduces serious heart disease

An injection pen containing semaglutide, sold by Novo Nordisk under the brand names Wegovy and Ozempic. | Photo by Jaap Arriens/NurPhoto via Getty Images A clinical trial suggests the drug could help people avoid the world’s leading cause of death. Diseases involving the heart and blood vessels are the leading cause of death globally and in the US. So anything that helps reduce deaths due to cardiovascular disease is a cause for celebratio…

Weight loss drug could cut the risk of heart attack and stroke risk

Meg Tirrell reports on what the study claims

65% Profit On Eli Lilly — 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug — Raising The Target - Novo Nordisk (NYSE:NVO)

Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.  Good News The results are out from the large scale study known as SELECT. The study was conducted by Danish company Novo Nordisk A/S (NYSE: NVO). The study compared in a double blind trial once weekly semaglutide 2.4mg with …

Risk of stroke and heart attack can be slashed by weight loss jabs, says study

Pharmaceutical company Novo Nordisk conducted a five-year study of semaglutide, which is sold as Wegovy. As part of its Select trial, the company recruited 17,604 adults over 45

Novo Nordisk says its weight loss drug Wegovy can cut risk of heart attack by 20%

Leading Danish pharma firm Novo Nordisk has claimed that its bestselling obesity drug Wegovy can cut the risk of heart attack, stroke or heart-related death by 20 per cent. The firm claimed that the clinical study, which is yet to be peer-reviewed, has proved that its drug has medical benefits beyond weight reduction. The clinical trial was conducted on 17,604 adults, aged 45 or older, with heart disease and obesity or who were overweight, but

This weight loss drug also cuts risk of heart problems, maker says

The maker of the weight loss drug Wegovy said a clinical trial showed it also reduced risk of heart attack and stroke.